Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000311751 | SCV000341147 | uncertain significance | not provided | 2016-05-18 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293169 | SCV001434166 | uncertain significance | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Revvity Omics, |
RCV000311751 | SCV003820138 | uncertain significance | not provided | 2021-04-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003993917 | SCV004813373 | uncertain significance | not specified | 2024-02-28 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.63644G>A (p.Arg21215His) results in a non-conservative amino acid change located in the A-band region of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.5e-05 in 246464 control chromosomes. c.63644G>A has been reported in the literature in unspecified individuals affected with Dilated cardiomyopathy, without strong evidence for causality (example, Al-Shafai_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Type 2J and other TTN-related diseases. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 34137518). ClinVar contains an entry for this variant (Variation ID: 287388). Based on the evidence outlined above, the variant was classified as uncertain significance. |